Dizal reports positive Phase I data for breast cancer therapy

Dizal reports positive Phase I data for breast cancer therapy

Submitted by admin on September 6, 2022 - 10:37am
Source: 
Clinical Trials Arena
News Tags: 
Dizal Pharmaceutical
clinical trials
breast cancer
HER2-positive metastatic breast cancer
DZD1516
Headline: 
Dizal reports positive Phase I data for breast cancer therapy
snippet: 

In the trial in HER2-positive metastatic breast cancer patients, DZD1516 was found to be well tolerated at doses ≤250mg.

Do Not Allow Advertisers to Use My Personal information